| Autor: |
Nagaharu, Keiki, Ohya, Eiko, Edahiro, Yoko, Hashimoto, Yoshinori, Ito, Tomoki, Gotoh, Akihiko, Nakamae, Mika, Kimura, Fumihiko, Koike, Michiaki, Kirito, Keita, Wada, Hideho, Usuki, Kensuke, Tanaka, Takayuki, Mori, Takehiko, Wakita, Satoshi, Saito, Toshiki I., Saito, Akiko M., Shimoda, Kazuya, Kurokawa, Toshiro, Tomita, Akihiro |
| Předmět: |
|
| Zdroj: |
Annals of Hematology; Sep2024, Vol. 103 Issue 9, p3535-3541, 7p |
| Abstrakt: |
Thrombosis in myeloproliferative neoplasms (MPNs) is an important clinical problem, and risk-stratified management is essential. To identify the clinical characteristics of thrombosis in patients with MPNs, a nationwide multi-institutional retrospective analysis (JSH-MPN-R18) was conducted. The aim of the present study was to perform a sub-analysis of JSH-MPN-R18 findings to clarify the predictive parameters for thrombosis among complete blood count (CBC) results. Among the patients enrolled in JSH-MPN-R18, those with essential thrombocythemia (ET; n = 1152) and polycythemia vera (PV; n = 456) were investigated. We analyzed and compared CBC parameters between patients with and those without any thrombotic events using Welch's T-test. Statistical analyses were performed using the R statistical software. Thrombotic events were observed in 74 patients with ET. In multivariate analysis, only the neutrophil ratio was slightly but significantly higher for ET patients with thrombosis than for those without (p < 0.05). Of note, the absolute neutrophil count (aNeu) was considered a useful predictive tool for thrombosis among patients classified as low-risk according to the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia. Among PV patients, those with thrombosis showed significantly higher hematocrit and aNeu than did those without thrombosis. As a thrombosis-associated factor, the neutrophil ratio was slightly but significantly elevated in patients with ET. This myeloid skew might reflect a higher value of JAK2 V617F allelic frequency in patients with ET with thrombosis; this was not clarified in JSH-MPN-R18. Further accumulation of evidence, including genetic information for JAK2 and other passenger mutations, is warranted. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink